Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

A new trial refutes this finding. The subjects, 636 patients who underwent successful coronary stenting, were randomized to an initial intravenous bolus and a 6-month oral regimen of either ...

Cava reported phenomenal fourth-quarter results. It's already live in 25 states and plans to accelerate store openings in 2025. Cava stock is expensive right now. Cava operates a small but growing ...

Cava reported a blowout fourth quarter with high comps growth and net income. It has a huge white space opportunity in opening new locations. Management's comps guidance was weak. However, the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

After hours: 7:59:33 pm GMT-5 ...

We value keeping the Device Guide up to date.